IGIV-C 10% Intravenous Immunoglobulin

intravenous immunoglobulin (IVIG), 10% solution

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IGIV-C 10% Intravenous Immunoglobulin, covering 2017-01-11 to 2017-01-11. Get the full timeline:

Most recent: Clinical Trial Update: Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10% [Phase 2]